Steno Diabetes Center is a hospital, research and teaching center dedicated to treating and managing diabetes, located in Gentofte, Denmark. It is named after Nicolas Steno. The center was established in 1991 as a result of the merge of the Niels Steensen Hospital and Hvidøre Hospital.

During the past decade, Steno Diabetes Center Copenhagen conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 8 clinical trials were completed, i.e. on average, 12.7% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 6 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Steno Diabetes Center Copenhagen" #1 sponsor was "Steno Diabetes Center Copenhagen" with 45 trials, followed by "Peter Rossing" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "University Hospital, Gentofte, Copenhagen" with 4 trials sponsored and "Lise Tarnow" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Steno Diabetes Center Copenhagen" #1 collaborator was "Steno Diabetes Center Copenhagen" with 11 trials as a collaborator, "University of Copenhagen" with 10 trials as a collaborator, "Novo Nordisk A/S" with 7 trials as a collaborator, "Rigshospitalet, Denmark" with 6 trials as a collaborator and "Aalborg University Hospital" with 4 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Steno Diabetes Center Copenhagen" are "Type 1 Diabetes" (17 trials), "Diabetes Mellitus, Type 1" (13 trials), "Diabetes Mellitus" (7 trials), "Diabetic Nephropathy" (7 trials) and "Diabetes Mellitus, Type 2" (6 trials). Many other conditions were trialed in "Steno Diabetes Center Copenhagen" in a lesser frequency.

Most popular intervention types in "Steno Diabetes Center Copenhagen" are "Drug" (47 trials), "Other" (19 trials), "Device" (17 trials), "Behavioral" (5 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Glucagon" (3 trials), "Liraglutide" (3 trials), "Metformin" (3 trials) and "Allopurinol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Steno Diabetes Center Copenhagen" are 89 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 11 active trials in "Steno Diabetes Center Copenhagen". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 69 completed trials in Steno Diabetes Center Copenhagen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Steno Diabetes Center Copenhagen, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 32 trials that are defined as “Not Applicable".

Steno Diabetes Center Copenhagen has several departments that took part in Clinical trials: "Center for Diabetes Research" - 2 trials